Ha Edward T, Nishi Takeshi, Takahashi Tatsunori, Yamazaki Tatsuro, Saito Yuichi, Kuramitsu Shoichi, Kawase Yoshiaki, Parikh Manish A, Waksman Ron, Kobayashi Yuhei
NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, USA.
Smidt Heart Institute, Cedars-Sinai Medical Center, California, USA.
JACC Cardiovasc Interv. 2025 Jul 14;18(13):1631-1642. doi: 10.1016/j.jcin.2025.05.032.
Discordance between fractional flow reserve (FFR) and nonhyperemic pressure ratios (NHPRs) can occur in about 20% of clinical cases, creating treatment dilemmas in the cardiac catheterization laboratory.
The authors sought to perform a systematic review and meta-analyses investigating the long-term outcome of deferral strategy in patients found to have discordant physiology.
The primary comparison tested the long-term prognosis of patients who were deferred for discordant physiology vs those deferred for concordant negative results. Various NHPRs were compared with FFR. The primary endpoint was a composite of death (all-cause or cardiac) and myocardial infarction/revascularization with several definitions. Secondary endpoint consisted of death or myocardial infarction. The study is registered with PROSPERO (CRD42024628393).
Six eligible trials with 9,854 intermediate lesions deferred for PCI were considered in the analysis. Compared with concordant-negative physiology (FFR/NHPRs), deferral of PCI for discordant physiology was associated with an increase in the primary endpoints (FFR/NHPRs: HR: 2.73 [1.95-3.80]; P < 0.00001 and FFR/NHPRs: HR: 3.29[2.33-4.64]; P < 0.00001). Secondary dichotomous analysis showed that deferral of PCI in both discordant groups was associated with an increase in the hard endpoints (death or myocardial infarction) compared with concordant-negative physiology. Exploratory analysis comparing revascularization vs deferral groups within discordant physiology demonstrated reduction in the primary endpoint in the FFR/NHPRs group, but not in the FFR/NHPRs group.
Deferral of PCI in discordant-physiology was associated with worse long-term outcomes compared with the concordant-negative physiology. There may be a benefit of revascularization in FFR/NHPRs lesions, which requires further investigation.
在约20%的临床病例中,血流储备分数(FFR)与非充血压力比值(NHPRs)之间可能出现不一致,这在心脏导管实验室中造成了治疗困境。
作者试图进行一项系统评价和荟萃分析,以研究对生理情况不一致的患者采取延迟策略的长期结局。
主要比较检验了因生理情况不一致而延迟治疗的患者与因一致性阴性结果而延迟治疗的患者的长期预后。将各种NHPRs与FFR进行比较。主要终点是死亡(全因或心脏原因)和心肌梗死/血运重建的复合终点,有多种定义。次要终点包括死亡或心肌梗死。该研究已在国际前瞻性系统评价注册库(PROSPERO,注册号:CRD42024628393)登记。
分析纳入了6项符合条件的试验,共9854例因PCI而延迟治疗的中度病变患者。与一致性阴性生理情况(FFR/NHPRs)相比,因生理情况不一致而延迟PCI与主要终点事件增加相关(FFR/NHPRs:风险比[HR]:2.73[1.95 - 3.80];P < 0.00001;FFR/NHPRs:HR:3.29[2.33 - 4.64];P < 0.00001)。次要二分法分析表明,与一致性阴性生理情况相比,两个不一致组延迟PCI均与硬终点事件(死亡或心肌梗死)增加相关。在生理情况不一致的情况下,对血运重建组与延迟治疗组进行探索性分析表明,FFR/NHPRs组主要终点有所降低,但FFR/NHPRs组未降低。
与一致性阴性生理情况相比,因生理情况不一致而延迟PCI与更差的长期结局相关。在FFR/NHPRs病变中进行血运重建可能有益,这需要进一步研究。